P V AshaRani1, Aditi Hombali2, Esmond Seow2, Wei Jie Ong2, Jit Hui Tan2, Mythily Subramaniam2. 1. Research Division, Institute of Mental Health, 10 Buangkok View, Singapore. Electronic address: Asharani_PEZHUMMOOTTIL_VASUDEVAN_N@imh.com.sg. 2. Research Division, Institute of Mental Health, 10 Buangkok View, Singapore.
Abstract
BACKGROUND: Methamphetamine (METH) use is on the rise globally, with the number of treatment seekers increasing exponentially across the globe. Evidence-based therapies are needed to meet rising treatment needs. This systematic review intends to appraise the existing evidence to identify effective non-pharmaceutical approaches for the treatment of METH use disorder. METHODS: Five electronic bibliographic databases-Ovid (Medline), Embase, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Web of Science and PsycINFO- were searched to identify relevant studies that were published between January 1995 to February 2020. Studies were selected and assessed by two independent reviewers. A systematic review of data from both randomised control trials (RCT) and non-RCTs was conducted to appraise the evidence. RESULTS: A total of 44 studies were included in the review. Behavioural interventions, i.e. cognitive behavioural therapy (CBT), contingency management (CM), exercise, residential rehabilitation based therapies, repetitive transcranial magnetic stimulation (rTMS), and matrix model demonstrated treatment efficacy in promoting abstinence, reducing methamphetamine use or craving in the participants. While CM interventions showed the strongest evidence favouring the outcomes assessed, tailored CBT alone or with CM was also effective in the target population. CONCLUSIONS: Behavioural interventions should be considered as the first line of treatment for methamphetamine use disorder. Future studies should address the longevity of the effects, and limitations due to smaller sample sizes and high dropout rates to enable better assessment of evidence.
BACKGROUND:Methamphetamine (METH) use is on the rise globally, with the number of treatment seekers increasing exponentially across the globe. Evidence-based therapies are needed to meet rising treatment needs. This systematic review intends to appraise the existing evidence to identify effective non-pharmaceutical approaches for the treatment of METH use disorder. METHODS: Five electronic bibliographic databases-Ovid (Medline), Embase, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Web of Science and PsycINFO- were searched to identify relevant studies that were published between January 1995 to February 2020. Studies were selected and assessed by two independent reviewers. A systematic review of data from both randomised control trials (RCT) and non-RCTs was conducted to appraise the evidence. RESULTS: A total of 44 studies were included in the review. Behavioural interventions, i.e. cognitive behavioural therapy (CBT), contingency management (CM), exercise, residential rehabilitation based therapies, repetitive transcranial magnetic stimulation (rTMS), and matrix model demonstrated treatment efficacy in promoting abstinence, reducing methamphetamine use or craving in the participants. While CM interventions showed the strongest evidence favouring the outcomes assessed, tailored CBT alone or with CM was also effective in the target population. CONCLUSIONS: Behavioural interventions should be considered as the first line of treatment for methamphetamine use disorder. Future studies should address the longevity of the effects, and limitations due to smaller sample sizes and high dropout rates to enable better assessment of evidence.
Authors: Johannes Petzold; Andy C Dean; Jean-Baptiste Pochon; Dara G Ghahremani; Richard De La Garza; Edythe D London Journal: Addict Biol Date: 2022-09 Impact factor: 4.093
Authors: Michael Viamonte; Delaram Ghanooni; John M Reynolds; Christian Grov; Adam W Carrico Journal: Curr HIV/AIDS Rep Date: 2022-06-14 Impact factor: 5.495
Authors: Francis Lee; Daniel Sheeler; Anna Hotton; Natascha Del Vecchio; Rey Flores; Kayo Fujimoto; Nina Harawa; John A Schneider; Aditya S Khanna Journal: Int J Drug Policy Date: 2022-02-24
Authors: Edouard Coupet; Gail D'Onofrio; Marek Chawarski; E J Edelman; Patrick G O'Connor; Patricia Owens; Shara Martel; David A Fiellin; Ethan Cowan; Lynne Richardson; Kristen Huntley; Lauren K Whiteside; Michael S Lyons; Richard E Rothman; Michael Pantalon; Kathryn Hawk Journal: Drug Alcohol Depend Date: 2020-11-26 Impact factor: 4.492
Authors: Mai Thi Ngoc Tran; Quang Hung Luong; Giang Le Minh; Michael P Dunne; Philip Baker Journal: Front Psychiatry Date: 2021-06-17 Impact factor: 4.157